On our Friday Trade To Black Podcast, hosts Shadd Dales and Anthony Varrell meet with two major cannabis advocates: former NFL defensive end Marvin Washington and Brady Cobb, Founder, and board member of Tyson 2.0. Both share the latest in their advocacy efforts and provide an update on the rescheduling chatter coming out of the capitol. Later, Dan from The Chart Guys joins to break down the latest trading action across major cannabis names, including: AdvisorShares Pure US Cannabis ETF ($MSOS, NYSEARCA), Trulieve Cannabis Corp ($TCNNF, OTCQX), Curaleaf Holdings Inc ($CURLF, OTCQX) and Tilray Brands Inc. ($TLRY, NASDAQ).
Marvin Washington played 11 seasons in the league, winning a Super Bowl with the Denver Broncos, and has since become one of the most recognized advocates for cannabis reform. From pushing for safer alternatives to opioids for athletes to lobbying lawmakers for legalization, Marvin shares what’s next in his mission and where real progress is happening.
President Trump has said a rescheduling decision could come within weeks. Washington argued athletes deserve recognition for pushing the conversation into the mainstream, noting their visibility has amplified public awareness. He projects cannabis use could be normalized across professional sports within a decade. He also suggested Texas could become a leader in cannabis if it transitions its hemp framework into a regulated adult-use market.
Brady Cobb also discusses the political implications of Trump rescheduling cannabis. He predicts Democrats would be divided—some claiming credit, others criticizing it as insufficient—while Republicans could face pressure to unify behind the move. Cobb emphasized that if the administration leads, federal agencies and Congress will be forced to harmonize rules across banking, healthcare, and interstate commerce. He also noted Florida’s legalization push faces challenges due to timing in a midterm election cycle, but stressed the state remains a critical battleground.
In the market segment, Dan breaks down the recent market insights on cannabis equities. Key levels he identified included $4.34 support and $5.38 resistance for MSOS, with sideways trading seen as healthy consolidation. Trulieve, GTI, Curaleaf, and Verano were highlighted with relative strength differences, while Village Farms (VFF) stood out as the most bullish U.S. cannabis name. Psychedelic stocks such as ATAI Life Sciences and MindMed are breaking multi-year highs, signaling strong investor interest.
